| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
First Department of Pathology, Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan
The modifying effects of five phenolic antioxidants on N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-initiated forestomach and glandular stomach carcinogenesis were investigated in male F344 rats. Groups of 20 rats were given an intragastric dose of 150 mg/kg body weight MNNG, and starting from 1 week later received diet supplemented with 0.8% catechol (CC), 1.0% 2-tert-butyl-4-methylphenol, 1.5% p-tert-butylphenol, 1.5% methylhydroquinone, 1.5% 4-methoxyphenol (4MP), or basal diet alone for 51 weeks. Further groups of 1015 rats were maintained as controls without prior treatment with MNNG. The incidences of squamous cell carcinoma of the forestomach in MNNG-treated animals were significantly elevated by the diets containing CC (P < 0.001), 2-tert-butyl-4-methylphenol (P < 0.001), or p-tert-butylphenol (P < 0.01), while the development of carcinoma in situ was inhibited by 4MP (P < 0.01). Treatment with CC, 2-tert-butyl-4-methylphenol, p-tert-butylphenol, or 4MP alone induced forestomach hyperplasia at incidences of 86.7, 40, 93.3, and 100%, respectively. In the pyloric region of the glandular stomach, the development of adenomatous hyperplasia and adenocarcinoma after MNNG treatment was significantly enhanced by diet containing CC (P < 0.001). Moreover, treatment with CC alone induced 100% adenomatous hyperplasia and induced adenocarcinoma in 20% of animals. These results clearly demonstrated that while antioxidants causing proliferation in forestomach epithelium can markedly enhance carcinogenesis in this tissue, others displaying the same or greater potential for generating a hyperplastic response, like 4MP, can exert an inhibitory effect. In addition, it was shown that CC, which is widely present in our environment, is an unequivocal glandular stomach carcinogen also possessing strong enhancing activity for MNNG-induced lesion development.
1 This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture and a grant from the Ministry of Health and Welfare of Japan.
2 To whom requests for reprints should be addressed, at First Department of Pathology, Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan.
Received 1/11/88. Revised 5/25/88. Accepted 6/17/88.
This article has been cited by other articles:
![]() |
K. Morita, H. Arimochi, and Y. Ohnishi In Vitro Cytotoxicity of 4-Methylcatechol in Murine Tumor Cells: Induction of Apoptotic Cell Death by Extracellular Pro-Oxidant Action J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 317 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hagiwara, Y. Takesada, H. Tanaka, S. Tamano, M. Hirose, N. Ito, and T. Shirai Dose-dependent Induction of Glandular Stomach Preneoplastic and Neoplastic Lesions in Male F344 Rats Treated with Catechol Chronically Toxicol Pathol, February 1, 2001; 29(2): 180 - 186. [Abstract] [PDF] |
||||
![]() |
M. Hirose, K. Hakoi, S. Takahashi, T. Hoshiya, K. Akagi, Cuilin, K. Saito, H. Kaneko, and T. Shirai Sequential Morphological and Biological Changes in the Glandular Stomach Induced by Oral Administration of Catechol to Male F344 Rats Toxicol Pathol, July 1, 1999; 27(4): 448 - 455. [Abstract] [PDF] |
||||
![]() |
F. A. Andersen Amended Final Report On the Safety Assessment of Pyrocatechol International Journal of Toxicology, January 1, 1997; 16(1_suppl): 11 - 58. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |